This document contains two discussion posts requiring responses. The first post discusses whether psilocybin treatment will be accessible to all groups and brings up ethical considerations. The second post discusses the application of ethical theories to decisions made by patients with mental health disorders and how cultures view and manage schizophrenia differently.